BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29078883)

  • 21. ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.
    Yamada A; Nagahashi M; Aoyagi T; Huang WC; Lima S; Hait NC; Maiti A; Kida K; Terracina KP; Miyazaki H; Ishikawa T; Endo I; Waters MR; Qi Q; Yan L; Milstien S; Spiegel S; Takabe K
    Mol Cancer Res; 2018 Jun; 16(6):1059-1070. PubMed ID: 29523764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
    Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
    Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F; Lim KG; Loveridge C; Long J; Pitson SM; Tigyi G; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2010 Oct; 22(10):1536-42. PubMed ID: 20570726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
    Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R
    Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer.
    Ohotski J; Edwards J; Elsberger B; Watson C; Orange C; Mallon E; Pyne S; Pyne NJ
    Int J Cancer; 2013 Feb; 132(3):605-16. PubMed ID: 22733311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model.
    Mousseau Y; Mollard S; Faucher-Durand K; Richard L; Nizou A; Cook-Moreau J; Baaj Y; Qiu H; Plainard X; Fourcade L; Funalot B; Sturtz FG
    Breast Cancer Res Treat; 2012 Jul; 134(1):31-40. PubMed ID: 22160641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoke inhibits efferocytosis via deregulation of sphingosine kinase signaling: reversal with exogenous S1P and the S1P analogue FTY720.
    Tran HB; Barnawi J; Ween M; Hamon R; Roscioli E; Hodge G; Reynolds PN; Pitson SM; Davies LT; Haberberger R; Hodge S
    J Leukoc Biol; 2016 Jul; 100(1):195-202. PubMed ID: 26792820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.
    Ohotski J; Rosen H; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2014 May; 26(5):1040-7. PubMed ID: 24486401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
    Chew WS; Wang W; Herr DR
    Pharmacol Res; 2016 Nov; 113(Pt A):521-532. PubMed ID: 27663260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration.
    Reines I; Kietzmann M; Mischke R; Tschernig T; Lüth A; Kleuser B; Bäumer W
    J Invest Dermatol; 2009 Aug; 129(8):1954-62. PubMed ID: 19194476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
    Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
    J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine-1-phosphate and estrogen signaling in breast cancer.
    Maczis M; Milstien S; Spiegel S
    Adv Biol Regul; 2016 Jan; 60():160-165. PubMed ID: 26601898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer.
    Tsuchida J; Nagahashi M; Nakajima M; Katsuta E; Rashid OM; Qi Q; Yan L; Okuda S; Takabe K; Wakai T
    J Surg Res; 2020 Dec; 256():645-656. PubMed ID: 32810665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine.
    Lankadasari MB; Aparna JS; Mohammed S; James S; Aoki K; Binu VS; Nair S; Harikumar KB
    Theranostics; 2018; 8(14):3824-3840. PubMed ID: 30083262
    [No Abstract]   [Full Text] [Related]  

  • 35. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
    Ottenlinger F; Schwiebs A; Pfarr K; Wagner A; Grüner S; Mayer CA; Pfeilschifter JM; Radeke HH
    Eur J Immunol; 2016 Apr; 46(4):941-51. PubMed ID: 26683421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
    Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
    J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines.
    Su K; Zeng P; Liang W; Luo Z; Wang Y; Lv X; Han Q; Yan M; Chen C
    Mediators Inflamm; 2017; 2017():3701385. PubMed ID: 28270699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
    Kihara A; Igarashi Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.